Trending
November 19, 2024 Georgiamune Appoints Mark Avagliano as Chief Business OfficerNovember 19, 2024 LB Pharmaceuticals Appoints Heather Turner as CEONovember 19, 2024 Kevin Krause Appointed CEO of ArrePAthNovember 14, 2024 myBiometry Secures $5M to Seek Regulatory Sanction for Device for Asthma PatientsNovember 13, 2024 Flagship Pioneering Appoints Craig Williams as CEO-Partner and Chief Executive Officer of Apriori Bio
Featured
November 19, 2024
Georgiamune Appoints Mark Avagliano as Chief Business Officer
GAITHERSBURG, Md., Nov. 19, 2024 (GLOBE NEWSWIRE) -- Today, Georgiamune Inc., a privately held, clinical-stage... Read more »
November 19, 2024
LB Pharmaceuticals Appoints Heather Turner as CEO
NEW YORK, Nov. 19, 2024 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc, a clinical-stage biopharmaceutical company... Read more »
November 19, 2024
Kevin Krause Appointed CEO of ArrePAth
PRINCETON, N.J.--(BUSINESS WIRE)--ArrePath, Inc., an emerging biotechnology company focused on applying deep phenotypic... Read more »
November 20, 2024
BioStem Technologies To Acquire Wound Care Products And Technologies From ProgenaCare Global
